AR008620A1 - Vacuna viva recombinante, fragmento de adn y virus iltv que la componen - Google Patents
Vacuna viva recombinante, fragmento de adn y virus iltv que la componenInfo
- Publication number
- AR008620A1 AR008620A1 ARP970102799A ARP970102799A AR008620A1 AR 008620 A1 AR008620 A1 AR 008620A1 AR P970102799 A ARP970102799 A AR P970102799A AR P970102799 A ARP970102799 A AR P970102799A AR 008620 A1 AR008620 A1 AR 008620A1
- Authority
- AR
- Argentina
- Prior art keywords
- virus
- vaccine
- make
- dna fragment
- iltv
- Prior art date
Links
- 241000701063 Gallid alphaherpesvirus 1 Species 0.000 title abstract 2
- 229960005486 vaccine Drugs 0.000 title abstract 2
- 239000012634 fragment Substances 0.000 title 1
- 239000002773 nucleotide Substances 0.000 abstract 3
- 125000003729 nucleotide group Chemical group 0.000 abstract 3
- 241000711404 Avian avulavirus 1 Species 0.000 abstract 2
- 241000287828 Gallus gallus Species 0.000 abstract 2
- 241000711450 Infectious bronchitis virus Species 0.000 abstract 2
- 241000700605 Viruses Species 0.000 abstract 2
- 241000271566 Aves Species 0.000 abstract 1
- 108091026890 Coding region Proteins 0.000 abstract 1
- 241000701047 Gallid alphaherpesvirus 2 Species 0.000 abstract 1
- 241000702626 Infectious bursal disease virus Species 0.000 abstract 1
- 241000711902 Pneumovirus Species 0.000 abstract 1
- 108010008038 Synthetic Vaccines Proteins 0.000 abstract 1
- 208000007502 anemia Diseases 0.000 abstract 1
- 239000000427 antigen Substances 0.000 abstract 1
- 102000036639 antigens Human genes 0.000 abstract 1
- 108091007433 antigens Proteins 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 230000037431 insertion Effects 0.000 abstract 1
- 238000003780 insertion Methods 0.000 abstract 1
- 229940031348 multivalent vaccine Drugs 0.000 abstract 1
- 244000052769 pathogen Species 0.000 abstract 1
- 230000001717 pathogenic effect Effects 0.000 abstract 1
- 229940124551 recombinant vaccine Drugs 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/16011—Herpesviridae
- C12N2710/16022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/16011—Herpesviridae
- C12N2710/16041—Use of virus, viral particle or viral elements as a vector
- C12N2710/16043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/20011—Coronaviridae
- C12N2770/20022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/20011—Coronaviridae
- C12N2770/20034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S424/00—Drug, bio-affecting and body treating compositions
- Y10S424/816—Viral vaccine for avian species, e.g. poultry or other birds
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Biophysics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biochemistry (AREA)
- Zoology (AREA)
- Molecular Biology (AREA)
- Wood Science & Technology (AREA)
- General Health & Medical Sciences (AREA)
- General Engineering & Computer Science (AREA)
- Virology (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Gastroenterology & Hepatology (AREA)
- Microbiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicinal Chemistry (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
La vacuna viva recombinante comprende, como vector, un virus ILTV que comprende y expresa al menos una secuencia nucleotídica heterologa, estandoinsertada esta secuencia nucleotídica en el sitio de insercion definido entre los nucleotidos 1624 y 2606 en SEQ ID NO:5. La vacuna puede comprender enparticular una secuencia codificante para un antígeno de un agente patogeno aviario elegido del grupo que comprende el virus de la enfermedad de Newcastle(NDV), el virus de la enfermedad de Gumboro (IBDV), el virus de la enfermedad de Marek (MDV), el virus de la bronquitis infecciosa (IBV), el virus de laanemia del pollo (CAV), el virus de la neumovirosis del pollo, preferiblemente bajo el control de un promoto eucariotico fuerte. Formula la vacunamultivalente.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9608243A FR2750866B1 (fr) | 1996-06-27 | 1996-06-27 | Vaccin vivant recombinant aviaire, utilisant comme vecteur le virus de la laryngotracheite infectieuse aviaire |
Publications (1)
Publication Number | Publication Date |
---|---|
AR008620A1 true AR008620A1 (es) | 2000-02-09 |
Family
ID=9493649
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP970102799A AR008620A1 (es) | 1996-06-27 | 1997-06-25 | Vacuna viva recombinante, fragmento de adn y virus iltv que la componen |
Country Status (13)
Country | Link |
---|---|
US (1) | US6153199A (es) |
EP (1) | EP0914458A1 (es) |
JP (1) | JP2000512844A (es) |
AR (1) | AR008620A1 (es) |
AU (1) | AU739374B2 (es) |
CO (1) | CO4700303A1 (es) |
FR (1) | FR2750866B1 (es) |
ID (1) | ID18351A (es) |
MA (1) | MA24222A1 (es) |
PE (1) | PE52599A1 (es) |
TN (1) | TNSN97109A1 (es) |
WO (1) | WO1997049826A1 (es) |
ZA (1) | ZA975618B (es) |
Families Citing this family (36)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6913751B2 (en) | 1992-06-12 | 2005-07-05 | Schering-Plough Veterinary Corporation | Recombinant avian herpesvirus useful in vaccine production |
EP1026246B1 (en) * | 1997-10-03 | 2006-11-29 | Zeon Corporation | Avian infectious herpesvirus recombinants and recombinant vaccines prepared with the use of the same |
AR031405A1 (es) * | 2000-11-21 | 2003-09-24 | Wyeth Corp | Metodos y vacunas para conferir proteccion in ovo contra la rinotraqueitis del pavo |
JP2002356441A (ja) * | 2001-03-15 | 2002-12-13 | Akzo Nobel Nv | 組換え伝染性喉頭気管炎ウイルスワクチン |
US7314715B2 (en) * | 2001-06-14 | 2008-01-01 | Schering-Plough Animal Health Corporation | Recombinant avian herpesvirus useful in vaccine production |
US20030157641A1 (en) * | 2001-11-16 | 2003-08-21 | Idec Pharmaceuticals Corporation | Polycistronic expression of antibodies |
IL161988A0 (en) | 2001-11-16 | 2005-11-20 | Corporation Idec Pharmaceutica | Polycistronic expression of antibodies |
EP1606419A1 (en) | 2003-03-18 | 2005-12-21 | Quantum Genetics Ireland Limited | Systems and methods for improving protein and milk production of dairy herds |
US7468273B2 (en) | 2003-05-01 | 2008-12-23 | Meial Limited | Canine GHRH gene, polypeptides and methods of use |
WO2005049794A2 (en) | 2003-11-13 | 2005-06-02 | University Of Georgia Research Foundation, Inc. | Methods of characterizing infectious bursal disease virus |
JP2007525217A (ja) | 2004-02-19 | 2007-09-06 | ザ ガバナーズ オブ ザ ユニバーシティー オブ アルバータ | レプチンプロモーター多型及びその使用 |
RS51324B (sr) | 2005-04-25 | 2010-12-31 | Merial Ltd. | Vakcine protiv nipah virusa |
US20080241184A1 (en) | 2005-08-25 | 2008-10-02 | Jules Maarten Minke | Canine influenza vaccines |
US7771995B2 (en) | 2005-11-14 | 2010-08-10 | Merial Limited | Plasmid encoding human BMP-7 |
JP2009515529A (ja) | 2005-11-14 | 2009-04-16 | メリアル リミテッド | 腎不全のための遺伝子療法 |
US7862821B2 (en) | 2006-06-01 | 2011-01-04 | Merial Limited | Recombinant vaccine against bluetongue virus |
US8871220B2 (en) | 2009-04-03 | 2014-10-28 | Merial Limited | Newcastle disease virus vectored avian vaccines |
ES2380289T3 (es) | 2009-11-30 | 2012-05-10 | United Cancer Research Institute | Nuevo clon del virus de la enfermedad de Newcastle, su fabricación y aplicación en el tratamiento médico del cáncer |
KR20120101572A (ko) | 2009-12-28 | 2012-09-13 | 메리얼 리미티드 | 재조합 ndv 항원 및 이의 용도 |
WO2012018813A2 (en) * | 2010-08-02 | 2012-02-09 | University Of Georgia Research Foundation, Inc. | Modified infectious laryngotracheitis virus (iltv) and uses thereof |
JP5913316B2 (ja) | 2010-08-31 | 2016-04-27 | メリアル リミテッド | ニューカッスル病ウイルスをベクターとするヘルペスウイルスワクチン |
WO2012090073A2 (en) | 2010-12-30 | 2012-07-05 | The Netherlands Cancer Institute | Methods and compositions for predicting chemotherapy sensitivity |
WO2012138789A2 (en) | 2011-04-04 | 2012-10-11 | Netherlands Cancer Institute | Methods and compositions for predicting resistance to anticancer treatment |
US20140296248A1 (en) | 2011-04-04 | 2014-10-02 | Stichting het Nederlands Kanker Instiuut-Antoni van Leeuwenhoek ziekenhuis | Methods and compositions for predicting resistance to anticancer treatment |
US9216213B2 (en) | 2011-04-20 | 2015-12-22 | Merial, Inc. | Adjuvanted rabies vaccine with improved viscosity profile |
WO2012149038A1 (en) | 2011-04-25 | 2012-11-01 | Advanced Bioscience Laboratories, Inc. | Truncated hiv envelope proteins (env), methods and compositions related thereto |
EP2714077B1 (en) | 2011-06-01 | 2018-02-28 | Merial, Inc. | Needle-free administration of prrsv vaccines |
DK2741740T3 (en) | 2011-08-12 | 2017-06-06 | Merial Inc | VACUUM-SUPPORTED CONSERVATION OF BIOLOGICAL PRODUCTS, IN PARTICULAR OF VACCINES |
WO2013093629A2 (en) | 2011-12-20 | 2013-06-27 | Netherlands Cancer Institute | Modular vaccines, methods and compositions related thereto |
WO2013138776A1 (en) | 2012-03-16 | 2013-09-19 | Merial Limited | Novel methods for providing long-term protective immunity against rabies in animals, based upon administration of replication-deficient flavivirus expressing rabies g |
US10709341B2 (en) | 2012-11-21 | 2020-07-14 | St. Jude Medical Luxembourg Holdings II S.a.r.l. | Devices, systems, and methods for pulmonary arterial hypertension (PAH) assessment and treatment |
US9556419B2 (en) | 2013-03-12 | 2017-01-31 | Merial Inc. | Reverse genetics Schmallenberg virus vaccine compositions, and methods of use thereof |
WO2014145712A1 (en) | 2013-03-15 | 2014-09-18 | Cardiomems, Inc. | Methods for the treatment of cardiovascular conditions |
EP2845904A1 (en) * | 2013-09-06 | 2015-03-11 | Ceva Sante Animale | Recombinant Marek's disease viruses and uses thereof |
MX2017005687A (es) | 2014-11-03 | 2017-08-21 | Merial Inc | Metodos para usar formulaciones para vacuna con microagujas para elicitar en animales inmunidad protectora contra virus de la rabia. |
JP2018523993A (ja) | 2015-06-23 | 2018-08-30 | メリアル インコーポレイテッド | Prrsv微量タンパク質含有組換えウイルスベクター並びにその作製及び使用方法 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP3339854B2 (ja) * | 1988-09-13 | 2002-10-28 | メリアル | ウイルスワクチン |
WO1992003554A1 (en) * | 1990-08-24 | 1992-03-05 | Arthur Webster Pty. Ltd. | Infectious laryngotracheitis virus vaccine |
WO1993025655A1 (en) * | 1992-06-12 | 1993-12-23 | Genencor International, Inc. | Enzymatic compositions and methods for producing stonewashed look on indigo-dyed denim fabric |
AU2946395A (en) * | 1994-06-30 | 1996-01-25 | Board of Regents of the University of Illinois, The | Recombinant infectious laryngotracheitis virus and vaccine |
FR2728794B1 (fr) * | 1994-12-30 | 1997-03-21 | Rhone Merieux | Vaccin recombinant aviaire a base de virus herpes aviaire, notamment contre la maladie de gumboro |
JP3964458B2 (ja) * | 1995-03-23 | 2007-08-22 | シェリング−プロウ・リミテッド | 組換え型伝染性喉頭気管炎ウイルスおよびその使用 |
-
1996
- 1996-06-27 FR FR9608243A patent/FR2750866B1/fr not_active Expired - Lifetime
-
1997
- 1997-06-23 MA MA24675A patent/MA24222A1/fr unknown
- 1997-06-25 ZA ZA975618A patent/ZA975618B/xx unknown
- 1997-06-25 EP EP97930591A patent/EP0914458A1/fr not_active Withdrawn
- 1997-06-25 AU AU34487/97A patent/AU739374B2/en not_active Expired
- 1997-06-25 TN TNTNSN97109A patent/TNSN97109A1/fr unknown
- 1997-06-25 WO PCT/FR1997/001138 patent/WO1997049826A1/fr not_active Application Discontinuation
- 1997-06-25 JP JP10502456A patent/JP2000512844A/ja active Pending
- 1997-06-25 AR ARP970102799A patent/AR008620A1/es unknown
- 1997-06-26 ID IDP972222A patent/ID18351A/id unknown
- 1997-06-27 CO CO97036155A patent/CO4700303A1/es unknown
- 1997-06-27 PE PE1997000548A patent/PE52599A1/es not_active Application Discontinuation
-
1998
- 1998-12-23 US US09/219,932 patent/US6153199A/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
CO4700303A1 (es) | 1998-12-29 |
ZA975618B (en) | 1998-12-28 |
FR2750866B1 (fr) | 1998-11-27 |
ID18351A (id) | 1998-04-02 |
AU739374B2 (en) | 2001-10-11 |
TNSN97109A1 (fr) | 2005-03-15 |
JP2000512844A (ja) | 2000-10-03 |
FR2750866A1 (fr) | 1998-01-16 |
AU3448797A (en) | 1998-01-14 |
PE52599A1 (es) | 1999-07-16 |
US6153199A (en) | 2000-11-28 |
MA24222A1 (fr) | 1997-12-31 |
WO1997049826A1 (fr) | 1997-12-31 |
EP0914458A1 (fr) | 1999-05-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR008620A1 (es) | Vacuna viva recombinante, fragmento de adn y virus iltv que la componen | |
Bayliss et al. | A recombinant fowlpox virus that expresses the VP2 antigen of infectious bursal disease virus induces protection against mortality caused by the virus | |
US20210401973A1 (en) | Multivalent recombinant avian herpes viruses and vaccines for immunizing avian species | |
Singh et al. | Re-emerging fowlpox: evaluation of isolates from vaccinated flocks | |
CO4650230A1 (es) | Vacuna viva recombinante aviaria, utilizando como vector el virus de la laringotraqueitis infecciosa aviaria | |
HUP9902790A2 (hu) | Madarakban alkalmazható polinukleotid-vakcinakészítmények | |
CO4650231A1 (es) | Vacuna viva recombinante aviaria que utiliza como vector el virus de laringotraqueitis infecciosa aviaria | |
AR020091A1 (es) | Adnc de paramyxovirus aviar (particularmente virus de la enfermedad de newcastle), arn, metodo para generar copias de virus infeccioso de paramyxovirusaviar, copia de virus infeccioso, vacuna que comprende dicho virus, vacuna viva, metodo para distinguir animales no vacunados o animales vacunados, y | |
RU2019136150A (ru) | Вакцины против рекомбинантного герпесвируса gallid 3, кодирующие гетерологичные антигены птичьего патогена | |
CA2166367A1 (en) | Live recombinant avian vaccine using an avian herpesvirus as vector | |
JP2006348044A (ja) | 鳥類ヘルペスウイルスをベースとした組換型鳥類用生ワクチン、特にガンボロ病用ワクチン | |
EP1298139A3 (en) | Avian herpes virus-based recombinant infectious bursal disease vaccine | |
AR037062A1 (es) | Vacuna adn adyuvada y utilizacion de un compuesto elegido entre los polimeros del acido acrilico o metacrilico y los copolimeros de anhidrido maleico y de derivado alquenilo para adyuvar a dicha vacuna adn | |
CA2110505A1 (en) | Infectious bursal disease virus recombinant poxvirus vaccine | |
AU729518B2 (en) | Recombinant fowlpox viruses and uses thereof | |
ECSP972164A (es) | Vacunas de uso aviario a base de virus de laringotraqueitis infecciosa | |
CA2478081A1 (en) | Multiple and multivalent dna vaccines in ovo | |
EP1908822B1 (en) | Infectious bursal disease virus mutants and vaccines | |
Sheppard | Viral vectors for veterinary vaccines | |
JPH04506901A (ja) | トリポックスウイルスプロモーター | |
RU2019101007A (ru) | Рекомбинантные непатогенные конструкции вируса болезни марека, кодирующие антигены вируса инфекционного ларинготрахеита и вируса инфекционного бурсита | |
RU2021120823A (ru) | Рекомбинантные вирусы и их применение | |
RU2021120675A (ru) | Рекомбинантные вирусы птичьего герпеса, содержащие несколько чужеродных генов | |
Audonnet et al. | Avian herpesvirus-based live recombinant avian vaccine, in particular against Gumboro disease | |
ECSP972183A (es) | Formula de vacuna polinucleotidica aviaria |